Zambon is a leading pharmaceutical and chemical multinational with a reputation for inventive and innovative thinking, flexibility and customer focus. Operating directly on three continents - Europe, North & South America and Asia - with 2500 employees in 14 countries and consolidated sales of €483m, Zambon is a multicultural Group with close links to its local markets and the international research community alike.

Headquartered in Bresso and originally founded in Vicenza in 1906, we value our track record for having initiated trends on the leading edge of the industry for 100 years, but are above all proud of the rich portfolio of ground-breaking products and dosage forms with which Zambon improves the quality of life of thousands of people worldwide.

Zambon's global scale and emphasis on individual initiative and teamwork have brought its companies a unique multiculturalism that motivates our people and enhances their contributions, creating an international perspective that hones their focus on our mission to improve quality of life in sickness and in health.

Zambon Company S.p.A. is the holding company of the Zambon's group , consisting of fine chemicals company ZaCh System, pharmaceuticals multinational Zambon S.p.A. and corporate venture specialist Z-Cube the corporate venture arm of the group Zambon, has achieved the launch of the three start-ups companies PharmEste s.r.l., SuppreMol GmbH and ProtAffin Biotechnologie AG based on highly innovative medicine projects.

The new Z-Cube business model is based on the selection, investment in and validation of innovative Drug Delivery Technology concepts. The technologies of interest are those showing the potential to generate innovative products bringing real benefits to patients in the therapeutic areas relevant for the parent company.